InvestorsHub Logo
Followers 51
Posts 3973
Boards Moderated 0
Alias Born 03/20/2014

Re: None

Thursday, 01/11/2024 2:49:52 PM

Thursday, January 11, 2024 2:49:52 PM

Post# of 465090
Dr. Missling did a great job in pointing out the superiority of Blarcamesine over the current AD SOC in administration (oral vs infusion) and effectiveness, greater and faster improvement minus severe side effects.

All my posts are my opinion only and shouldn’t be used for decisions regarding purchasing or selling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News